Navigation Links
Former Deputy Commissioner of FDA Highlights Value of Small Distributors
Date:12/7/2011

WASHINGTON, Dec. 7, 2011 /PRNewswire/ -- Dr. Scott Gottlieb, the former deputy commissioner for medical and scientific affairs with the U.S. Food and Drug Administration, testified before the U.S. Senate Committee on Finance that small distributors play an important role in helping reallocate drugs to ensure that patients get the treatment they need. The committee hearing centered on how to address the drug shortage issues currently facing the nation.

A practicing physician and a resident fellow at the American Enterprise Institute, Gottlieb's prepared statements noted:

"Some also blame these shortages on what they refer to as 'manipulation' of drug middlemen or so-called 'gray market' distributors. However unpleasant, the markups charged by small distributors often reflect their higher costs, and aren't simply profiteering as has been alleged. ... Many small distributors routinely provide critical-need products to hospitals that cannot otherwise secure these same products from their primary wholesalers. This is especially important in rural areas. Moreover, small and independent distributors typically must purchase products at prices above the Wholesale Acquisition Costs. They cannot access drugs at the lower prices that GPOs negotiate with manufacturers. As a result, the difference between the higher prices charged by small distributors and those typically provided to hospitals by GPOs can often be misleading. What might appear as an enormously priced drug being offered by a small distributor may actually reflect an appropriate mark-up."

During the hearing, discussion focused on whether the FDA should set up a clearinghouse of scarce drugs for health care providers to help circumvent potential bottlenecks in distribution. Gottlieb pointed out that this is a role small distributors already play in the market.

"I would just add to that a lot of the reallocation that does take place in the market place is the small distributors reallocating product, and often times they have to acquire the product at a much higher price than what GPO might acquire it at," Gottlieb said. "I raise this just because there has been a lot of discussion about the so-called gray market and profiteering, but a lot of the small distributors who are acquiring the drugs at higher prices – and significantly higher prices – and then selling obviously them at higher prices as well, are performing an important market-clearing function."

Gottlieb's comments highlight the vital role small distributors play in health care – a role on which the National Coalition of Pharmaceutical Distributors has been working to educate people for several months.

About NCPD

The National Coalition of Pharmaceutical Distributors is a national trade association representing the wellbeing and interests of the independent and specialty pharmaceutical distribution industry. NCPD is dedicated to securing the pharmaceutical supply chain and is aggressively working to help enact federal legislation to revamp the nation's chain of custody laws for prescription pharmaceutical products.


'/>"/>
SOURCE National Coalition of Pharmaceutical Distributors
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
2. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
3. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
4. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
5. Michigan Life Science and Innovation Center Opens in Former Pfizer Facility
6. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
7. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
8. Former Miss USA Shawnae Jebbia Shines with Siemens Pure
9. Secure eHealth, LLC Engages as a Consultant GSI Health Whose Principal and CEO is the Former Senior Advisor to National Coordinator for Health Information Technology
10. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
11. SCAI Statement on the Hospitalization of Former President Bill Clinton
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... On Thursday, the NASDAQ Composite ended the trading ... edged 0.36% higher, to finish at 19,191.93; and the S&P ... as six out of nine sectors ended the day in ... Services equities: Myriad Genetics Inc. (NASDAQ: MYGN ), ... Inc. (NASDAQ: INCR ), and La Quinta Holdings ...
(Date:12/2/2016)... 2016  Today, Simpson Healthcare Executives, a global leader ... selected as winners of multiple awards at the 2016 ... the PLATINUM level, Blue Zones Menu at the GOLD ... Level, and our proprietary 3ConneX Platform at the HONORABLE ... we are excited to showcase our new Platinum and ...
(Date:12/2/2016)... Columbia , December 2, 2016 bioLytical Laboratories ... gegeben, ab diesem Monat seinen  INSTI HIV-Selbsttests  in einer Version mit geringeren ... ... New: INSTI Self Test! (PRNewsFoto/bioLytical ... ,      (Photo: http://photos.prnewswire.com/prnh/20161201/444833 ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... More than ... Alabama are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. ... for area students and operating support to UNCF-member institutions, including Miles College, Oakwood ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a leading ... the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The ... education, experience, and professional associations. , One the most frequently honored surgeons ...
(Date:12/2/2016)... ... 02, 2016 , ... The PAINWeekEnd Regional Conference will be ... in Honolulu, offering local frontline clinicians the opportunity to extend their certified continuing ... for supplemental training related to pain management has surged dramatically in recent years, ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Yisrayl Hawkins, at ... into how this current generation fits into Bible Prophecy. Yisrayl says this generation, known ... pointing to this conclusion, showing how the details line up exactly with Bible Prophecy ...
Breaking Medicine News(10 mins):